CAR T-cell therapy as option for diseases of the peripheral nervous system Our work shows that the targeted use of CAR T-cells is possible and of significant clinical benefit, even for severe ...

Peripheral T-cell lymphomas (PTCLs) represent approximately 12% of all lymphoid tumors worldwide. The vast majority of them belong to the not otherwise specified (NOS) angioimmunoblastic or ...

Postural sway velocity as a screening tool in diabetic peripheral neuropathy represents a potential early marker of balance impairment and fall risk. The 2025 annual meeting of the Peripheral Nerve ...

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy-induced ...

Methods: 115 patients with chemotherapy-induced peripheral neuropathy (for ≥1 month, with average pain rating of ≥4/10 or ECOG sensory neuropathy ≥1/3) were randomized in this double-blind, ...

3.2 Peripheral blood immune cell profiles in acute NMOSD (including DMT-NMOSD and non-DMT-NMOSD) and control To tease out peripheral blood immune cell profiles in acute NMOSD, comparative analyses ...

The global peripheral neuropathy treatment market is projected to achieve significant growth, with an increase of USD 481.6 million anticipated from 2024 to 2029, advancing at a CAGR of 4.5% ...